Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination

1. GethingPW, SmithDL, PatilAP, TatemAJ, SnowRW, et al. (2010) Climate change and the global malaria recession. Nature 465: 342–345.

2. MurrayCJL, RosenfeldLC, LimSS, AndrewsKG, ForemanKJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413–431.

3. CotterC, SturrockHJW, HsiangMS, LiuJ, PhillipsAA, et al. (2013) The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet doi:10.1016/S0140-6736(13)60310-4

4. BousemaT, GriffinJT, SauerweinRW, SmithDL, ChurcherTS, et al. (2012) Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med 9 (1) e1001165 doi:10.1371/journal.pmed.10011659

5. GethingP, PatilA, SmithD, GuerraC, ElyazarI, et al. (2011) A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J 10: 378.

6. BejonP, WilliamsTN, LiljanderA, NoorAM, WambuaJ, et al. (2010) Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med 7 (7) e1000304 doi:10.1371/journal.pmed.1000304

7. BousemaT, DrakeleyC, GesaseS, HashimR, MagesaS, et al. (2010) Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis 201: 1764–1774.

8. CarterR, MendisKN, RobertsD (2000) Spatial targeting of interventions against malaria. Bull World Health Organ 78: 1401–1411.

9. YangzomT, GueyeCS, NamgayR, GalappaththyGN, ThimasarnK, et al. (2012) Malaria control in Bhutan: case study of a country embarking on elimination. Malar J 11: 9.

10. ChuquiyauriR, ParedesM, PeñataroP, TorresS, MarinS, et al. (2012) Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop 121: 292–302.

11. WesolowskiA, EagleN, TatemAJ, SmithDL, NoorAM, et al. (2012) Quantifying the impact of human mobility on malaria. Science 338: 267–270.

12. WHO (2012) Disease surveillance for malaria elimination: an operational manual. Geneva: WHO. Available: http://www.who.int/malaria/publications/atoz/9789241503334/en/index.html. Accessed Feb 2013.

13. BousemaJ, GouagnaL, DrakeleyC, MeutstegeA, OkechB, et al. (2004) Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 3: 18.

14. MacauleyC (2005) Aggressive active case detection: a malaria control strategy based on the Brazilian model. Soc Sci Med 60: 563–573.

15. AlvesFP, DurlacherRR, MenezesMJ, KriegerH, SilvaLHP, et al. (2002) High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 66: 641–648.

16. PintoJ, SousaCA, GilV, FerreiraC, GonçalvesL, et al. (2000) Malaria in São Tomé and Príncipe: parasite prevalences and vector densities. Acta Trop 76: 185–193.

17. ParkCG, ChwaeYJ, KimJI, LeeJH, HurGM, et al. (2000) Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax. Am J Trop Med Hyg 62: 720–725.

18. LaishramDD, SuttonPL, NandaN, SharmaVL, SobtiRC, et al. (2012) The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J 11: 29.

19. SandersK, Smith GueyeC, PhillipsAA, GoslingR (2012) Active case detection for malaria elimination: a confusion of acronyms and definitions. Malar Chemo Contr Elim 1.

20. The malERA Consultative Group on Monitoring Evaluation and Surveillance (2011) A research agenda for malaria eradication: monitoring, evaluation, and surveillance. PLoS Med 8 (1) e1000400 doi:10.1371/journal.pmed.1000400

21. GriffinJT, HollingsworthTD, OkellLC, ChurcherTS, WhiteM, et al. (2010) Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 7 (8) e1000324 doi:10.1371/journal.pmed.1000324

22. MoonenB, CohenJM, SnowRW, SlutskerL, DrakeleyC, et al. (2010) Operational strategies to achieve and maintain malaria elimination. Lancet 376: 1592–1603.

23. StresmanG, KamangaA, MoonoP, HamapumbuH, MharakurwaS, et al. (2010) A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia. Malar J 9: 265.

24. APMEN Country Partner Strategy and Intervention Matrices (2011). Asia Pacific Malaria Elimination Network. Available: http://apmen.org/country-resources/. Accessed Jan 2013.

25. YekutielP (1960) Problems of epidemiology in malaria eradication. Bull World Health Organ 22: 669–683.

26. ZizhaoL, LuoyuanS, LianZ, DongfangL, YunpuS (1999) Control strategies of malaria in Henan Province, China. Southeast Asian J Trop Med Public Health 30: 240–242.

27. PremanathM (1997) Control of malaria: the rapid fever surveillance programme. J Assoc Physicians India 45: 853–856.

28. Lysenko A (1961) Organization of case detection in some malaria eradication programmes in the Americas. Available: https://extranetwhoint/iris/restricted/bitstream/10665/64820/1/WHO_Mal_301pdf. Accessed Feb 2013.

29. Ray A (1964) The discipline and dynamics of active case detection procedure under surveillance operations in a malaria eradication programme. Available: https://extranetwhoint/iris/restricted/bitstream/10665/65196/1/WHO_Mal_453pdf. Accessed Feb 2013.

30. KernS, TionoA, MakangaM, GbadoeA, PremjiZ, et al. (2011) Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis. Malar J 10: 210.

31. SutcliffeCG, KobayashiT, HamapumbuH, ShieldsT, MharakurwaS, et al. (2012) Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study. PLoS ONE 7 (2) e31396 doi:10.1371/journal.pone.0031396

32. TionoA, OuedraogoA, OgutuB, DiarraA, CoulibalyS, et al. (2013) A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Malar J 12: 79.

33. WHO (2012) Community-based reduction of malaria transmission. Available: http://whqlibdoc.who.int/publications/2012/9789241502719_eng.pdf. Accessed Feb 2013.

34. TatarskyA, AboobakarS, CohenJM, GopeeN, BheecarryA, et al. (2011) Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS ONE 6 (9) e23832 doi:10.1371/journal.pone.0023832

35. Al-Zedjali MS, Director, Directorate of Malaria Eradication, Ministry of Health (2008) Malaria Elimination in Oman. Malaria Elimination Group Meeting. Brienz, Switzerland.

36. KanekoA, TaleoG, KalkoaM, YamarS, KobayakawaT, et al. (2000) Malaria eradication on islands. Lancet 356: 1560–1564.

37. MagnaniR, SabinK, SaidelT, HeckathornD (2005) Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 19: S67–S72.

38. HaySI, SmithDL, SnowRW (2008) Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 8: 369–378.

39. AsihPB, RoziIE, HerdianaH, PratamaNR, HidayatiAP, et al. (2012) The baseline distribution of malaria in the initial phase of elimination in Sabang Municipality, Aceh Province, Indonesia. Malar J 11: 291.

40. JorgensenP, NambanyaS, GopinathD, HongvanthongB, LuangphengsoukK, et al. (2010) High heterogeneity in Plasmodium falciparum risk illustrates the need for detailed mapping to guide resource allocation: a new malaria risk map of the Lao People's Democratic Republic. Malar J 9: 59.

41. YukichJ, TaylorC, EiseleT, ReithingerR, NauhassenayH, et al. (2013) Travel history and malaria infection risk in a low-transmission setting in Ethiopia: a case control study. Malar J 12: 33.

42. DwyerDM, StricklerH, GoodmanRA, ArmenianHK (1994) Use of case-control studies in outbreak investigations. Epidemiol Rev 16: 109–123.

43. GuthmannJP, Llanos-CuentasA, PalaciosA, HallAJ (2002) Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru. Trop Med Int Health 7: 518–525.

44. BousemaJT, SchneiderP, GouagnaLC, DrakeleyCJ, TostmannA, et al. (2006) Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis 193: 1151–1159.

45. SutherlandCJ, OrdR, DunyoS, JawaraM, DrakeleyCJ, et al. (2005) Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med 2 (4) e92 doi:10.1371/journal.pmed.0020092

46. SeidahmedOME, MohamedeinMMN, ElsirAA, AliFT, MalikEFM, et al. (2008) End-user errors in applying two malaria rapid diagnostic tests in a remote area of Sudan. Trop Med Int Health 13: 406–409.

47. SawaP, ShekalagheSA, DrakeleyCJ, SutherlandCJ, MweresaCK, et al. (2013) Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial. J Infect Dis doi: 10.1093/infdis/jit077

48. ClydeDF (1962) Mass administration of an antimalarial drug combining 4-aminoquinoline and 8-aminoquinoline in Tanganyika. Bull World Health Organ 27: 203–212.

49. CoulibalyB, ZoungranaA, MockenhauptFP, SchirmerRH, KloseC, et al. (2009) Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS ONE 4 (5) e5318 doi:10.1371/journal.pone.0005318

50. WHO Evidence Review Group (2012) The safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. Available: http://wwwwhoint/malaria/mpac/sep2012/primaquine_single_dose_pf_erg_meeting_report_aug2012pdf. Accessed Jan 2013.

51. KatzTM, MillerJH, HebertAA (2008) Insect repellents: historical perspectives and new developments. J Am Acad Dermatol 58: 865–871.

52. KimaniEW, VululeJM, KuriaIW, MugishaF (2006) Use of insecticide-treated clothes for personal protection against malaria: a community trial. Malar J 5: 63.

53. GoslingRD, GhaniAC, DeenJL, von SeidleinL, GreenwoodBM, et al. (2008) Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? Malar J 7: 54.

54. SturrockHJW, NovotnyJM, KuneneS, DlaminiS, ZuluZ, et al. (2013) Reactive case detection for malaria elimination: real-life experience from an ongoing programme in Swaziland. PLoS ONE 8: e63830 doi:10.1371/journal.pone.0063830

55. MuellerI, GalinskiMR, BairdJK, CarltonJM, KocharDK, et al. (2009) Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555–566.

56. WongsrichanalaiC, BarcusMJ, MuthS, SutamihardjaA, WernsdorferWH (2007) A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 77: 119–127.

57. BaltzellKA, ShakelyD, HsiangMS, KemereJ, AliAS, et al. (2012) Prevalence of PCR detectable malaria infection among febrile patients with a negative Plasmodium falciparum specific rapid diagnostic test in Zanzibar. Am J Trop Med Hyg 88: 289–291.

58. WHO (2009) Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 2 (2009). Geneva: World Health Organization. Available: http://www.finddiagnostics.org/export/sites/default/resource-centre/reports_brochures/docs/rdt_malariaRd2_web.pdf Accessed Nov 2012

59. KimJY, KimHH, NaBK, KimYJ, SohnY, et al. (2012) Estimating the malaria transmission of Plasmodium vivax based on serodiagnosis. Malar J 11: 257.

60. TaylorWR, WhiteNJ (2004) Antimalarial drug toxicity: a review. Drug Saf 27: 25–61.

61. KimS, NguonC, GuillardB, DuongS, ChyS, et al. (2011) Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE 6 (12) e28357 doi:10.1371/journal.pone.0028357

62. KinzerM, ChandK, BasriH, LedermanE, SusantiA, et al. (2010) Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu. Malar J 9: 89.

63. OkellLC, GhaniAC, LyonsE, DrakeleyCJ (2009) Submicroscopic infection in Plasmodium falciparum–endemic populations: a systematic review and meta analysis. J Infect Dis 200: 1509–1517.

64. OkellLC, BousemaT, GriffinJT, OuedraogoAL, GhaniAC, et al. (2012) Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 3: 1237.

65. CordrayMS, Richards-KortumRR (2012) Emerging Nucleic Acid-Based Tests for Point-of-Care Detection of Malaria. Am J Trop Med Hyg 87: 223–230.

66. IshengomaDS, LwitihoS, MadebeRA, NyagondeN, PerssonO, et al. (2011) Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence. Malar J 10: 6.

67. CongpuongK, SaeJengA, Sug-aramR, AruncharusS, DarakapongA, et al. (2012) Mass blood survey for malaria: pooling and realtime PCR combined with expert microscopy in north-west Thailand. Malar J 11: 288.

68. CorranP, ColemanP, RileyE, DrakeleyC (2007) Serology: a robust indicator of malaria transmission intensity? Trends Parasitol 23: 575–582.

69. AlonsoPL, BarnwellJW, BellD, HansonK, MendisK, et al. (2011) A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med 8 (1) e1000396 doi:10.1371/journal.pmed.1000396

70. BousemaT, YoussefRM, CookJ, CoxJ, AleganaVA, et al. (2010) Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis 16: 392–399.

71. ShanksGD (2012) Control and Elimination of Plasmodium vivax. Adv Parasitol 80: 301–341.

72. von SeidleinL, GreenwoodBM (2003) Mass administrations of antimalarial drugs. Trends Parasitol 19: 452–460.

73. EnkMJ, LimaACL, MassaraCL, CoelhoPMZ, SchallVT (2008) A combined strategy to improve the control of Schistosoma mansoni in areas of low prevalence in Brazil. Am J Trop Med Hyg 78: 140–146.

74. MassaraCL, PeixotoSV, EnkMJ, da Silva BarrosH, dos Santos CarvalhoO, et al. (2006) Evaluation of an improved approach using residences of schistosomiasis-positive school children to identify carriers in an area of low endemicity. Am J Trop Med Hyg 74: 495–499.